Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...
Sight Sciences Inc (NASDAQ: SGHT) released the six-month SAHARA randomized controlled trial comparing interventional eyelid procedures enabled by TearCare Technology to Restasis
MENLO PARK, Calif., July 20, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve...
Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside is expected from the accelerating iAccess and iPRIME launches.
Dozens of lobbyists and other K Street types have already maxed out to at least one candidate as of the filing deadline.